Labcorp Holdings LH Diagnostics — Supplies Expense

Other segment segments

Similar metrics at other companies

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

VCYTTesting revenue — Laboratory supplies and reagents expense

$12.31M-5.8%

DHRDiagnostics — Capital expenditures, gross

$144M+25.2%

BIOClinical Diagnostics — Cost of goods sold

$181.8M+1.5%

ABTDiagnostic Products — Selling, general, and administrative

$448M+14.3%

RVTYDiagnostics — Segment Selling, general and administrative expenses

$90.19M+0.3%

Questions, answered.

What is Labcorp Holdings's diagnostics — supplies expense?

Labcorp Holdings (LH) reported diagnostics — supplies expense of $613.5M in Q1 2026.

How has Labcorp Holdings's diagnostics — supplies expense changed year-over-year?

Labcorp Holdings's diagnostics — supplies expense increased by 4.6% year-over-year, from $586.6M to $613.5M.

What is the long-term trend for Labcorp Holdings's diagnostics — supplies expense?

Over 3 years (2022 to 2025), Labcorp Holdings's diagnostics — supplies expense has grown at a 7.2% compound annual growth rate (CAGR), from $1.91B to $2.36B.

What does diagnostics — supplies expense mean?

This represents the costs associated with consumables, reagents, testing kits, and other materials required to perform diagnostic laboratory tests. It is a variable cost that scales directly with testing volume and is a key driver of gross margin.